Bettmann M A, Bourdillon P D, Barry W H, Brush K A, Levin D C
Radiology. 1984 Dec;153(3):583-7. doi: 10.1148/radiology.153.3.6387783.
The effects on cardiac hemodynamics and serum parameters of a standard contrast agent (sodium methylglucamine diatrizoate [Renografin 76]) were compared with the effects of a new nonionic agent (iohexol) in a double-blind study in 51 patients undergoing coronary angiography and left ventriculography. No significant alteration in measured blood parameters occurred with either contrast agent. Hemodynamic changes occurred with both, but were significantly greater with the standard Renografin than with the low-osmolality, nonionic iohexol. After left ventriculography, heart rate increased and peripheral arterial pressure fell with both agents, but less with iohexol. Following coronary artery injections, heart rate and arterial pressure decreased with both agents, but the changes were more marked and occurred earlier with the standard contrast material. It is concluded that iohexol causes less alteration in cardiac function than does the agent currently most widely used. Nonionic contrast material is likely to improve the safety of coronary angiography, particularly in those patients at greatest risk.
在一项双盲研究中,对51例接受冠状动脉造影和左心室造影的患者,比较了一种标准造影剂(泛影葡胺钠[Renografin 76])与一种新型非离子型造影剂(碘海醇)对心脏血流动力学和血清参数的影响。两种造影剂均未使所测血液参数发生显著改变。两种造影剂均可引起血流动力学变化,但标准的泛影葡胺引起的变化明显大于低渗非离子型碘海醇。左心室造影后,两种造影剂均可使心率增加、外周动脉压下降,但碘海醇引起的变化较小。冠状动脉注射后,两种造影剂均可使心率和动脉压下降,但标准造影剂引起的变化更明显且出现更早。得出的结论是,碘海醇对心脏功能的改变小于目前使用最广泛的造影剂。非离子型造影剂可能会提高冠状动脉造影的安全性,尤其是对那些风险最大的患者。